Acuity officer Neil Ashe proposes $2.94M share sale

The proposed shares are identified with performance share unit awards that vested on October 24, 2026.

Available on EDGAR 10/30/2026 - 04:14 PM EDT Accepted by SEC EDGAR 10/30/2026 - 04:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Acuity Inc. (DE) officer Neil Ashe reported a proposed sale of 9,217 common shares, with an aggregate market value of $2,936,682.43 and a listed sale date of October 30, 2026. The notice identifies the shares with performance share unit awards that vested on October 24, 2026, and says they were granted as part of the issuer’s equity compensation plan.

It also lists prior sales of 22,060 shares for an aggregate sales price of $7,000,217.88 on October 28, 2026, and 8,187 shares for $2,656,199.78 on October 29, 2026.

Key Figures

Proposed shares: 9,217 shares Aggregate market value: $2,936,682.43 Shares sold: 22,060 shares +3 more

6 metrics

Proposed shares 9,217 shares Neil Ashe’s proposed sale

Aggregate market value $2,936,682.43 Proposed shares

Shares sold 22,060 shares October 28, 2026

Aggregate sales price $7,000,217.88 October 28, 2026 sale

Shares sold 8,187 shares October 29, 2026

Aggregate sales price $2,656,199.78 October 29, 2026 sale

Key Terms

performance share unit awards, issuer equity compensation plan, Rule 144

3 terms

performance share unit awards financial

"Vesting of performance share unit awards"

issuer equity compensation plan financial

"Granted as part of issuer equity compensation plan"

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AYI shares did Neil Ashe report for sale?

Neil Ashe reported a proposed sale of 9,217 Acuity Inc. (DE) common shares, with an aggregate market value of $2,936,682.43 and a listed sale date of October 30, 2026. The shares are identified with performance share unit awards that vested on October 24, 2026.

What AYI shares did Neil Ashe sell in October 2026?

The notice lists sales of 22,060 common shares for an aggregate sales price of $7,000,217.88 on October 28, 2026, and 8,187 shares for $2,656,199.78 on October 29, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193485
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ACUITY INC. (DE)
SEC File Number	001-16583
Address of Issuer	1170 PEACHTREE STREET NE SUITE 1200 ATLANTA GEORGIA 30309
Phone	404-853-1400
Name of Person for Whose Account the Securities are To Be Sold	ASHE NEIL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	9217	2936682.43	29695521	10/30/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/24/2026	Vesting of performance share unit awards	ACUITY INC. (DE)			9217	10/24/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Neil Ashe 1170 PEACHTREE STREET NE SUITE 1200 ATLANTA GA 30309	Common Stock	10/28/2026	22060	7000217.88
Neil Ashe 1170 PEACHTREE STREET NE SUITE 1200 ATLANTA GA 30309	Common Stock	10/29/2026	8187	2656199.78

144: Remarks and Signature

Remarks
Date of Notice	10/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Neil Ashe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)